Cheng-wei Tom Chang

Title: Innovations of Cheng-wei Tom Chang

Introduction

Cheng-wei Tom Chang is a notable inventor based in Logan, UT (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel compounds for medical applications. With a total of 7 patents to his name, his work focuses on addressing various fungal and bacterial diseases.

Latest Patents

Chang's latest patents include "Amphiphilic aminoglycoside connexin hemichannel inhibitors," which presents novel molecules and methods for targeting Connexin Hemichannels. This invention features an amphiphilic kanamycin molecule with specific substitutions that reduce antimicrobial activity. Another significant patent is "Amphiphilic kanamycin compositions and methods," which relates to bioactive amphiphilic kanamycin compounds. These compounds are designed to treat and prevent various fungal and bacterial diseases, showcasing Chang's innovative approach to addressing health challenges.

Career Highlights

Throughout his career, Cheng-wei Tom Chang has worked with esteemed institutions such as Utah State University and Texas Tech University System. His research has led to advancements in the understanding and treatment of infectious diseases, making him a valuable contributor to the scientific community.

Collaborations

Chang has collaborated with notable colleagues, including Jon Y Takemoto and Dong Chen. These partnerships have further enhanced his research and development efforts in the field of biotechnology.

Conclusion

Cheng-wei Tom Chang's innovative work and numerous patents reflect his dedication to advancing medical science. His contributions are vital in the ongoing fight against infectious diseases, and his research continues to inspire future innovations.